TELA Bio (TELA) Gross Profit Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.06% |
| Dec 31, 2025 | 22.58% |
| Sep 30, 2025 | 8.64% |
| Jun 30, 2025 | 27.38% |
| Mar 31, 2025 | 10.37% |
| Dec 31, 2024 | -3.47% |
| Sep 30, 2024 | 23.77% |
| Jun 30, 2024 | 8.55% |
| Mar 31, 2024 | 43.53% |
| Dec 31, 2023 | 42.17% |
| Sep 30, 2023 | 41.95% |
| Jun 30, 2023 | 55.74% |
| Mar 31, 2023 | 57.99% |
| Dec 31, 2022 | 44.48% |
| Sep 30, 2022 | 59.04% |
| Jun 30, 2022 | 28.76% |
| Mar 31, 2022 | 44.27% |
| Dec 31, 2021 | 54.53% |
| Sep 30, 2021 | 40.01% |
| Jun 30, 2021 | 143.98% |
| Mar 31, 2021 | 57.50% |
| Dec 31, 2020 | 23.59% |
| Sep 30, 2020 | 26.23% |
| Jun 30, 2020 | 9.33% |
| Mar 31, 2020 | 22.36% |
| Dec 31, 2019 | 188.23% |
| Sep 30, 2019 | 90.49% |